Optimal timing of neutron irradiation for boron neutron capture therapy after intravenous infusion of sodium borocaptate in patients with glioblastoma

International Journal of Radiation Oncology Biology Physics

Volumn 51, Issue 1, 2001, Pages 120-130

  Kageji, Teruyoshi ^a   Nagahiro, Shinji ^a   Kitamura, Katsushi ^a   Nakagawa, Yoshinobu ^b   Hatanaka, Hiroshi ^c   Haritz, Dietrich ^d   Grochulla, Frank ^d   Haselsberger, Klaus ^e   Gabel, Detlef ^f  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b National Hospital Organization   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

^d Clinic for Neurosurgery   (Germany)

^e UNIVERSITY OF GRAZ   (Austria)

^f UNIVERSITY OF BREMEN   (Germany)

Author keywords

Boron neutron capture therapy; Boron uptake; BSH; Malignant glioma; Pharmacokinetics

Indexed keywords

BORON; DRUG DOSAGE; DRUG PRODUCTS; NEUTRON IRRADIATION; PHARMACOKINETICS; SODIUM COMPOUNDS; TUMORS;

GLIOBLASTOMA;

ONCOLOGY;

BOROCAPTATE; BORON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; DRUG UPTAKE; EUROPE; EVALUATION; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; JAPAN; MALE; MEAN RESIDENCE TIME; NEUTRON CAPTURE THERAPY; NEUTRON RADIATION; PRIORITY JOURNAL; RADIATION DOSE; SCHOOL CHILD; STEADY STATE;

ADULT; AGED; BOROHYDRIDES; BORON NEUTRON CAPTURE THERAPY; BRAIN NEOPLASMS; CHILD; FEMALE; GLIOBLASTOMA; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SULFHYDRYL COMPOUNDS; TIME FACTORS;

EID: 0035450986     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01605-4     Document Type: Article

References (41)

1. Biological effects and therapeutic possibilities of neutron
2. Neutron capture therapy with boron in the treatment of glioblastoma multiforme
3. Introduction
4. Penetration of brain and brain tumor. VII. Tumor-binding sulfhydryl boron compounds
5. Supplementary pharmacological study between 1972 and 1977 on purified mercaptoundecahy drododecaborate
6. Capillary permeability and boron distribution in ethylnitrosourea-induced rat glioma
7. Boron-10-mercaptoundecahy drododecaborate distribution in rat brain tumour
8. Boron neutron capture therapy of a rat glioma
9. Uptake of boron into human gliomas of athymic mice and into syngenic cerebral gliomas of rat after intracarotid infusion of sulfhydryl borane
10. Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy
11. Boron neutron capture therapy: The past to the present
12. Boron neutron capture therapy - Clinical brain tumor study
13. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory
14. European clinical trials of boron neutron capture therapy for glioblastoma
15. Performance of sulfhydryl boron hydride in patients with grade III and IV astrocytoma: A basis for boron neutron capture therapy
16. Borocaptate sodium (BSH) pharmacokinetics in glioma patients
17. 11SH (BSH) in patients with malignant glioma as precondition for boron neutron capture therapy (BNCT)
18. 11SH in patients with glioblastoma
19. Biodistribution of boron sulfhydryl (BSH) in patients with intracranial tumors
20. Biodistribution of boron sulfhydryl for boron neutron capture therapy in patients with intracranial tumors
21. 11SH (BSH) in patients with malignant brain tumours as prerequisite for a phase I clinical of boron neutron capture
22. Boron uptake by human brain tumors and quality control of boron compounds
23. 11SH) with time interval from BSH infusion in patients with malignant glioma
24. 11SH) in patients with intracranial tumors
25. Quantitative neutron capture radiography for studying the biodistribution of tumor-seeking boron containing compounds
26. A nonlinear least squares program based on differential equations, MULTI (RANGE), for microcomputers
27. 7Li reaction from borocaptate sodium and the relative biological effectiveness of recoil protons for induction of brain damage in boron neutron capture therapy
28. The therapeutic ratio in BNCT
29. Determination of boron in tissues and cell using direct-current plasma atomic emission spectroscopy
30. 10B concentration in tissue for neutron capture therapy by prompt gamma ray spectroscopy
31. Prompt gamma ray spectrometry for in vivo measurement of boron-10 concentration in rabbit brain tissue
32. The role of boron MRI in boron neutron capture therapy
33. Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations
34. Boron neutron capture therapy of brain tumors: Biodistribution, pharmacokinetics, and radiation dosimetry of Sodium Borocaptate in patients with gliomas
35. 11SH on cellular and subcellular level in tumor tissue of glioma patients in boron neutron capture therapy
36. Present status and perspectives of boron neutron capture therapy
37. Boron-10-mercaptoundecahy dodecaborate distribution in human brain tumors as studied by neutron-induced alpha-autoradiography
38. 11SH
39. Subcellular distribution of various boron compounds and implications for their efficacy in boron neutron capture therapy by Monte Carlo simulations
40. Safety and efficacy in boron neutron capture therapy